◆ TICKERBASE · US STOCK FINANCIAL DATA LIBRARY

HomeAll stocks › IRIX

IRIDEX Corporation (IRIX) Financial History

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Medical Devices · DATA UPDATED 2026-07-09

IRIDEX Corporation (IRIX) operates in the Medical Devices industry and is headquartered in Mountain View, United States with about 93 employees. Its market capitalization is roughly $20 million. In the fiscal year ended 2025-12-31, IRIX reported $53M in revenue and ($4M) in net income.

IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology.

Interactive charts & full statements → Open the IRIX valuation workbench →

IRIX Revenue & Earnings History — Annual Income Statement

Income statement2025-12-312024-12-312023-12-312022-12-31
Total Revenue$53M$49M$52M$57M
Gross Profit$19M$20M$22M$25M
Operating Income (EBIT)($3M)($8M)($10M)($8M)
Net Income($4M)($9M)($10M)($8M)

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

IRIX Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement2026-03-312025-12-312025-09-302025-06-302025-03-31
Total Revenue$12M$15M$12M$14M$12M
Gross Profit$5M$6M$4M$5M$5M
Operating Income (EBIT)($0M)$0M($1M)($1M)($0M)
Net Income($0M)($0M)($2M)($1M)($2M)

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

IRIX Free Cash Flow History

IRIX Balance Sheet History

Balance sheet2025-12-312024-12-312023-12-312022-12-312021-12-31
Total Assets$29M$29M$34M$42M
Total Liabilities$24M$27M$25M$25M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive IRIX viewer.

Other Companies in Medical Devices

← IRHOAll stocksIRM →

About TickerBase · Data methodology & sources

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.